Search is Powered by Google
Cancer / Oncology News

Map Of Medicine Supports Cancer Networks To Implement Cancer Reform Strategy, UK

Main Category: Cancer / Oncology
Article Date: 14 May 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:3 stars

3 (1 votes)

Article Opinions: 0 posts

The Map of Medicine announced that from today onwards, it will be partnering with all cancer networks across England to localise the cancer care pathways already provided by 'the Map'. The partnership is key to enabling the networks to achieve targets set out in the 'Cancer Reform Strategy', including improving early detection of cancers, reducing referral times and extending screening programmes.

This is particularly important given recent reports that inconsistencies exist in the delivery of cancer services across England. A recent survey found that women are not always being appropriately referred for breast cancer and that, in some cases, GPs are unsure when to refer breast cancer patients as urgent cases. Inappropriate referrals can have a direct impact on the quality of care received by some cancer patients across the country.

Professor Mike Richards, National Cancer Director says: "One of our key areas for action, highlighted in the 'Cancer Reform Strategy,' is to reduce cancer inequalities. This unique initiative between the Map of Medicine and the cancer networks will help us in achieving this aim."

By localising the evidence based cancer pathways, which are already available on the Map of Medicine, the cancer networks will help improve the standardisation of cancer services and ensure all healthcare professionals working in the NHS in England can access the latest evidence and guidance on cancer care and management.

There are already 120 Map of Medicine care pathways or 'Healthguides' accessible directly to patients via the NHS Choices website.

Map of Medicine


Ad Banner - the most access to the best resources


Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Schizophrenia

Sign up to receive newsletters / news alerts
MedReader RSS Reader


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating Prostate Cancer Symptoms image Treating Prostate Cancer Symptoms

Many men will have advanced prostate cancer without any noticeable symptoms. Treatment for these patients is a bit different than for other patients with prostate cancer. Learn about these differences...

View more videos...